CEO Ellen Kullman lost her battle with activist shareholders and ultimately was replaced by Edward Breen, who will oversee the company's merger with [hotlink]Dow Chemical[/hotlink] (No. 56 on this year's Fortune 500) and which is expected to close by late 2016.
Company Info
| CEO | Edward D. Breen |
| Sector | Chemicals |
| Industry | Chemicals |
| HQ Location | Wilmington, DE |
| Website | www.dupont.com |
| Years on Fortune 500 List | 22 |
| Employees | 52,000 |
Key Financials (last fiscal year)
| Revenues ($M) | $27,940 |
| Profits ($M) | $1,953 |
| Assets ($M) | $41,166 |
| Total Stockholder Equity ($M) | $9,993 |
| Market Value — as of March 31, 2016 ($M) | $55,289 |
Profit Ratios
| Profit as % of Revenues | 7% |
| Profits as % of Assets | 4.7% |
| Profits as % of Stockholder Equity | 19.5% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 216 |
| EPS % Change (from 2014) | -44.9% |
| EPS % Change (5 year annual rate) | -8% |
| EPS % Change (10 year annual rate) | 0.4% |
Total Return
| Total Return to Investors (2015) | -2.6% |
| Total Return to Investors (5 year, annualized) | 10.4% |
| Total Return to Investors (10 year, annualized) | 9% |
